Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	-97.46	6.58	259.07
Graham Fair Price	85.89	0.36	0.19
PEG	0.00	0.00	0.00
Price/Book	55.51	0.21	0.13
Price/Cash Flow	50.03	-8.80	-17.61
Prices/Earnings	-53.92	4.41	9.56
Price/Sales	-73.03	1.01	3.76
Price/FCF	50.03	-8.80	-17.61
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	-13.19	0.35	0.40
Operating Margin	993.69	0.23	-0.02
ROA	246.51	< 0.005	< 0.005
ROE	< 0.005	0.01	237.50
ROIC	< 0.005	< 0.005	4688.82
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	0.00	0.00
EPS QOQ	0.00	0.00	0.00
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	4889.52	821.74	-83.19
Days Sales Outstanding (DSO)	0.00	< 0.005	100.00
Inventory Turnover	0.02	0.11	495.02
Debt/Capitalization	0.22	0.23	1.77
Quick Ratio	0.04	0.12	174.02
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	0.68	0.69	1.18
Cash	0.04	0.11	160.12
Capex	< 0.005	0.00	inf
Free Cash Flow	< 0.005	-0.02	-214.91
Revenue	0.02	0.14	483.47
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	1.40	1.45	3.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	162.49	2.69	-98.34
Naive Interpretation	Member

06 - Financial Health · Weak

Rating